Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2014, Article ID 426976, 8 pages
Clinical Study

Mortality in Levodopa-Treated Parkinson's Disease

1Movement Disorders Program, Department of Neurology, Medical College of Georgia, Georgia Regents University, 1429 Harper Street HF-1154, Augusta, GA 30912, USA
2Movement Disorders Division, Department of Neurology, University of Virginia, P.O. Box 800394, Charlottesville, VA 22908, USA
3Parkinson’s & Movement Disorders Center, Department of Neurology, Virginia Commonwealth University, 6605 West Broad Street, First Floor, Suite C Richmond, VA 23230, USA
4Clinical Development, Forest Laboratories, Inc., Jersey City, NJ, USA

Received 2 September 2013; Revised 13 November 2013; Accepted 14 November 2013; Published 28 January 2014

Academic Editor: Jan O. Aasly

Copyright © 2014 John C. Morgan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Alison Callahan, Juan Jose Cifuentes, and Michel Dumontier, “An evidence-based approach to identify aging-related genes in Caenorhabditis elegans,” Bmc Bioinformatics, vol. 16, 2015. View at Publisher · View at Google Scholar
  • Allon Goldberg, Catherine L. Curtis, and Jeffrey A. Kleim, “Linking Genes to Neurological Clinical Practice: The Genomic Basis for Neurorehabilitation,” Journal Of Neurologic Physical Therapy, vol. 39, no. 1, pp. 52–61, 2015. View at Publisher · View at Google Scholar
  • Gustavo Costa Fernandes, Mariana Peixoto Socal, Artur Francisco Schumacher Schuh, and Carlos R. M. Rieder, “Clinical and Epidemiological Factors Associated with Mortality in Parkinson’s Disease in a Brazilian Cohort,” Parkinson's Disease, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Ali M. Al-Radaideh, and Eman M. Rababah, “The role of magnetic resonance imaging in the diagnosis of Parkinson's disease: A review,” Clinical Imaging, vol. 40, no. 5, pp. 987–996, 2016. View at Publisher · View at Google Scholar
  • Yi-Huei Chen, Ching-Heng Lin, Yu-Hsuan Wu, Wei-Ju Lee, and Ming-Hong Chang, “Premotor symptoms as predictors of outcome in parkinsons disease: A case-control study,” PLoS ONE, vol. 11, no. 8, 2016. View at Publisher · View at Google Scholar
  • Amit Kumar, Swati Dudhal, Abinaya T. Sundari, Mallikarjuna Sunkara, Hyder Usman, Anurag Varshney, and Asok Mukhopadhyay, “Dopaminergic-primed fetal liver mesenchymal stromal-like cells can reverse parkinsonian symptoms in 6-hydroxydopamine-lesioned mice,” Cytotherapy, vol. 18, no. 3, pp. 307–319, 2016. View at Publisher · View at Google Scholar
  • Nicholas J. Lavalley, Sunny R. Slone, Huiping Ding, Andrew B. West, and Talene A. Yacoubian, “14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening,” Human Molecular Genetics, vol. 25, no. 1, pp. 109–122, 2016. View at Publisher · View at Google Scholar
  • Radu Constantinescu, Barbro Eriksson, Yvonne Jansson, Bo Johnels, Björn Holmberg, Thordis Gudmundsdottir, Annika Renck, Peter Berglund, and Filip Bergquist, “Key clinical milestones 15 years and onwards after DBS-STN surgery − a retrospective analysis of patients that underwent surgery between 1993 and 2001,” Clinical Neurology and Neurosurgery, 2017. View at Publisher · View at Google Scholar
  • Amosova, Smolentseva, Gavrilov, Maslyuk, and Yu.V. Pavlov, “An analysis of causes of death in patients with Parkinson’s disease,” Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova, vol. 117, no. 6, pp. 70–72, 2017. View at Publisher · View at Google Scholar